Background: Recently, a high incidence of BRCA1 cancer predisposing mutation was described among patients with Uterine Serous Papillary Carcinoma (USPC). A BRCA2 germline mutation in a USPC patient has never been reported.
Case: A 65-year-old Ashkenazi Jewish woman was diagnosed with USPC Stage III A.